ストックスクリーナーアプリを入手
0.296
0.47%
-0.0014
Gt Biopharma Inc (GTBP) 最新ニュース
GT Biopharma Shareholders Approve Reverse Split and Incentive Plan - TipRanks
GT Biopharma (NASDAQ: GTBP) wins approval for reverse split and share plan changes - Stock Titan
GT Biopharma Q2 Results: Net Loss Falls To $4.5 Million - scanx.trade
Gt Biopharma Reports Second Quarter 2026 Financial Results - TradingView
GTBP: Q2 2026 net loss narrowed to $4.5M as clinical programs advance and cash runway extends to Q4 2026 - TradingView
GT Biopharma Reports Second Quarter 2026 Financial Results - The Manila Times
GT Biopharma (GTBP) cuts net loss but flags going concern and Nasdaq risk - Stock Titan
GT Biopharma Inc (NASDAQ: GTBP) Share Price, GTBP Stock News, GTBP Share Price & Updates - kalkine.ca
GT Biopharma Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
GT Biopharma Inc (GTBP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GT Biopharma Inc (GTBP) Stock News Today - TradingKey
GT Biopharma’s TriKE® Program: Pipeline, Progress, & What’s Ahead - SmallCap Asia
GTBP Q2'26 Earnings: revenue estimate is 0 USD - TradingView
GT Biopharma (GTBP) Slips 4.65% to $0.29, Testing Critical Support Near $0.28Trend Reversal Picks - dars.gov.et
GT BIOPHARMA INC (GTBP) Stock Chart - ChartMill
GT Biopharma Edges Higher as Biotech Sector Sees Renewed Interest — GTBP Hovers Near Key LevelsSmart Beta Flow - po-news-eg.net
GT Biopharma Inc (GTBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GT Biopharma Inc (GTBP) Cash Flow - TradingKey
GT Biopharma Inc (GTBP) Income Statement - tradingkey.com
GTBP|GT Biopharma Inc|Price:0.335|Chg%:+0.011 - TradingKey
GT Biopharma Inc (GTBP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GTBP|GT Biopharma Inc|Price:0.310|Chg%:-0.011 - TradingKey
GT Biopharma Inc (GTBP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GT Biopharma Inc (GTBP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GTBP|GT Biopharma Inc|Price:0.324|Chg%:-0.011 - TradingKey
GT Biopharma(GTBP) Stock Options Chain | Quotes & News - Moomoo
GT Biopharma, Inc. Revenue Breakdown – NASDAQ:GTBP - TradingView
GT Biopharma Inc (GTBP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Price to earnings forward of GT Biopharma, Inc. – NASDAQ:GTBP - TradingView
Price to earnings forward of GT Biopharma Inc – SWB:OXIA - TradingView
Immunotherapy Breakthroughs Propel Clinical Momentum Ahead of ESMO Congress - Baystreet.ca
GT Biopharma (GTBP) Slides to $0.42 Amid Continued Selling PressureLast Point Resistance - po-news-eg.net
GT Biopharma (GTBP) Revenue BreakdownMain Composition - Moomoo
A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs - Newswire Canada
GTBP News | GT BIOPHARMA INC (NASDAQ:GTBP) - ChartMill
GT Biopharma (GTBP) plans reverse stock split and larger 2022 incentive plan - Stock Titan
Enterprise value to EBITDA forward of GT Biopharma, Inc. – NASDAQ:GTBP - TradingView
A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs - PR Newswire Canada
Enterprise value to EBITDA forward of GT Biopharma Inc – MUN:OXIA - TradingView
Enterprise value to revenue forward of GT Biopharma, Inc. – NASDAQ:GTBP - TradingView
Price to book forward of GT Biopharma Inc – FWB:OXIA - TradingView
Enterprise value to EBITDA forward of GT Biopharma Inc – FWB:OXIA - TradingView
Enterprise value to revenue forward of GT Biopharma Inc – FWB:OXIA - TradingView
Enterprise value to EBIT forward of GT Biopharma, Inc. – NASDAQ:GTBP - TradingView
Price to sales forward of GT Biopharma Inc – FWB:OXIA - TradingView
Price to earnings forward of GT Biopharma Inc – FWB:OXIA - TradingView
GT Biopharma Inc Actuals & Estimates (SWB:OXIA) - TradingView
GTBP Q1 2026 Earnings: EPS Misses Estimates as Pre‑Revenue Biotech Continues Clinical DevelopmentEPS Guidance Update - dars.gov.et
OXIA Forecast — Price Target — Prediction for 2027 - TradingView
GT Biopharma Inc Actuals & Estimates (NASDAQ:GTBP) - TradingView
GTBP Forecast — Price Target — Prediction for 2027 - TradingView
GT Biopharma Inc (GTBP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Frontier tech research, news & data - MLQ.ai
GT Biopharma Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances NK PlatformROE Trend Analysis - po-news-eg.net
GTBP PE Ratio & Valuation, Is GTBP Overvalued - Intellectia AI
GT Biopharma Stocklong-term cancer therapy strategy under review - AD HOC NEWS
GT Biopharma (NASDAQ: GTBP) proposes reverse split and 3.5M share plan increase - Stock Titan
0.52%
0.07%
大文字化:
|
ボリューム (24 時間):